The approval for the CRSwNP indication was based on data from the randomized, double-blind, placebo-controlled WAYPOINT trial.
The FDA approved tezepelumab-ekko (TEZSPIRE; AstraZeneca/Amgen) on Friday as an add-on maintenance treatment in patients aged ...
Six years since the FDA blessed Sanofi and Regeneron’s Dupixent as the first biologic to treat chronic rhinosinusitis with nasal polyps (CRSwNP), a second biologic therapy has broken through with a | ...
Cold snare polypectomy for colorectal polyps smaller than 1 cm significantly reduced the risk for delayed bleeding and improved procedural efficiency compared with hot snare polypectomy, according to ...
Here are 12 statistics on ambulatory surgery center and physician Medicare payments for gastroenterology/endoscopy procedures involving polypectomy, according to Boston Scientific’s 2014 Coding & ...
AstraZeneca and Amgen’s TEZSPIRE® (tezepelumab -ekko) has been approved in the US for the add-on maintenance treatment of ...
The U.S. Food and Drug Administration has approved Amgen and AstraZeneca's drug for a type of chronic inflammatory sinus ...
Nasal polyps are teardrop-shaped, soft tissue growths that form in the lining of your nasal cavity and sinuses (the hollow spaces in the bones of your face). Nasal polyps are benign, which means they ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback